|
| Press Releases |
|
 |
|
| Wednesday, June 29, 2022 |
|
|
Jacobson Pharma Announces FY2022 Annual Results |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of essential medicines, specialty drugs and branded healthcare products, today announced the annual results of the Company and its subsidiaries (collectively the "Group") for the year ended 31 March 2022 ("FY2022" or the "Reporting Period"). more info >> |
|
| Wednesday, June 15, 2022 |
|
|
万隆、雅各臣及健倍苗苗成立合资公司 拓展大中华区及亚洲专科药及品牌医疗保健市场 |
| 万隆控股集团有限公司（「万隆」，连同其附属公司「万隆集团」; 股份代号：0030.HK），其控股股东为云南白药集团股份有限公司（证券代号000538.SHE） more info >> |
|
|
萬隆、雅各臣及健倍苗苗成立合資公司 拓展大中華區及亞洲專科藥及品牌醫療保健市場 |
| 萬隆控股集團有限公司（「萬隆」，連同其附屬公司「萬隆集團」; 股份代號：0030.HK），其控股股東為雲南白藥集團股份有限公司（證券代號000538.SHE） more info >> |
|
|
Ban Loong, Jacobson & JBM Form Joint Venture to Tap Specialty Drugs and Branded Healthcare Markets in Greater China and Asia |
| Ban Loong Holdings Limited ("Ban Loong", together with its subsidiaries, "Ban Loong Group"; stock code: 0030.HK), of which Yunnan Baiyao Group Co., Ltd. (stock code: 000538.SHE) is the controlling shareholder, Jacobson Pharma Corporation Limited ("Jacobson", together with its subsidiaries (excluding JBM Group) more info >> |
|
| Monday, March 14, 2022 |
|
|
雅各臣獲主席增持股份至超過六成 |
| 從事基礎藥物、專科藥物及品牌醫療保健產品研發、生產、市場推廣及銷售的領先企業 ─ 雅各臣科研製藥有限公司（「公司」；連同其附屬公司統稱「集團」；股份代號：2633 ) 獲集團主席岑廣業先生於二零二一年十二月十五日至二零二二年三月十四日期間 more info >> |
|
|
Jacobson Pharma's Chairman Uplifts Shareholding to Above 60% |
| Mr. Derek Sum, Chairman and Chief Executive Officer of Jacobson Pharma Corporation Limited (the "Company"; together with its subsidiaries, the "Group"; Stock Code: 2633), a leading company engaged in the research more info >> |
|
| Friday, November 26, 2021 |
|
|
雅各臣公布二零二二财年中期业绩 |
| 从事基础药物、专科药物及品牌医疗保健产品研发、生产、市场推广及销售的领先企业─雅各臣科研制药有限公司（「雅各臣」或「公司」；股份代号：2633 )今天公布公司及其附属公司（统称「集团」）截至二零二一年九月三十日止六个月（「报告期」）的中期业绩。 more info >> |
|
|
雅各臣公佈二零二二財年中期業績 |
| 從事基礎藥物、專科藥物及品牌醫療保健產品研發、生產、市場推廣及銷售的領先企業─雅各臣科研製藥有限公司（「雅各臣」或「公司」；股份代號：2633 )今天公佈公司及其附屬公司（統稱「集團」）截至二零二一年九月三十日止六個月（「報告期」）的中期業績。 more info >> |
|
|
Jacobson Pharma Announces FY2022 Interim Results |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaging in the research, development, production, marketing and sale of essential medicines more info >> |
|
| Tuesday, June 29, 2021 |
|
|
雅各臣公布二零二一财年全年业绩 |
| 从事基础药物、专科药物及品牌医疗保健品研发、生产、市场推广及销售的领先企业─雅各臣科研制药有限公司（「雅各臣」或「公司」；股份代号：2633 )今天公布公司及其附属公司（统称「集团」）于截至二零二一年三月三十一日止年度（「二零二一财年」或「报告期」）的全年业绩。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Your Go-To Travel Checklist for Smarter, Reward-Focused Travel Planning
May 18, 2026 11:12 HKT/SGT
|
|
|
JCB and Wonder Advance Cashless Taxi Payments in Hong Kong
May 18, 2026 10:00 JST
|
|
|
「星樞計劃」正式發布 鈞達股份多家下屬公司成為上海太空算力產業生態夥伴發起及首批單位
May 17, 2026 12:51 HKT/SGT
|
|
|
Shoucheng Holdings' First-Quarter Report Shows 18% Core Profit Growth and Sustained High Shareholder Returns
May 16, 2026 08:49 HKT/SGT
|
|
|
首程控股一季報核心利潤增長18% 高股東回報持續兌現
May 16, 2026 08:49 HKT/SGT
|
|
|
Tabor Redefines Anti-Drone Testing with Software-Defined SDR Platform
May 16, 2026 07:00 HKT/SGT
|
|
|
NEC completes construction of approximately 2,250 km EMCS submarine cable linking Pacific island nations
May 15, 2026 17:36 JST
|
|
|
Fujitsu and Science Tokyo launch joint research hub for quantum hardware advancement and talent development
May 15, 2026 17:12 JST
|
|
|
Fujitsu and IBM Japan formalize collaboration in healthcare sector
May 15, 2026 16:42 JST
|
|
|
三菱重工機械システム、関越自動車道での交通混雑緩和キャンペーンに協力
May 15, 2026 15:30: JST
|
|
|
富士通と東京科学大学、量子ハードウェア技術の進展と人材育成に向けた共同研究を開始
May 15, 2026 15:30: JST
|
|
|
Toyota Launches All-New Land Cruiser "FJ" Series in Japan
May 15, 2026 15:24 JST
|
|
|
Mitsubishi Motors Signs Memorandum of Understanding with FPT Japan Holdings to Study Collaboration in Software and Digital Domain
May 15, 2026 15:10 JST
|
|
|
NEC Launches Orbital Transfer Vehicle Development Project Aiming for Asia's First Vehicle Deployment through JAXA's Space Strategy Fund Program
May 15, 2026 14:55 JST
|
|
|
Substantial Shareholder Wei Fu Increases Shareholding in Everest Medicines Again, Marking His Second Share Purchase in 2026 and Demonstrating Long-term Confidence
May 15, 2026 13:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
